Adicet Bio, Inc. (ACET) vs Alps Group Inc (ALPS)
A side-by-side comparison of Adicet Bio, Inc. and Alps Group Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACET
Adicet Bio, Inc.
$6.47HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ALPS
Alps Group Inc
$0.40HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ACET vs ALPS
growth of $100 · dividends reinvested · last 1yACET -54.6% (-54.6%/yr)ALPS -96.7% (-96.7%/yr)ACET compounded faster over this window
Log scale — wide-divergence pair
ACET ALPS
ACET vs ALPS: by the numbers
- •ALPS is the larger company ($67M vs $60M market cap).
- •Both run net losses; ACET's is the smaller (0.00% vs -41.36% net margin).
Metrics side by side
Valuation
| Metric | ACET | ALPS |
|---|---|---|
| P/B ratio | 0.50 | N/A |
Profitability
| Metric | ACET | ALPS |
|---|---|---|
| Gross margin | 0.00% | 32.09% |
| Operating margin | 0.00% | -69.62% |
| Net margin | 0.00% | -41.36% |
| ROE | -82.38% | N/A |
| ROIC | -79.68% | N/A |
Growth (annualized)
| Metric | ACET | ALPS |
|---|---|---|
| Total return CAGR (5Y) | -44.24% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.